Long-term nicotine exposure changes neuronal acetylcholine nicotinic receptor (nAChR) subtype expression in the brains of smokers and experimental animals. The aim of this study was to investigate nicotine-induced changes in nAChR expression in two models commonly used to describe the effects of nicotine in animals: operant (two-lever presses) intravenous self-administration (SA) and passive subcutaneous nicotine administration via an osmotic minipump (MP). In the MP group, alpha 4 beta 2 nAChRs were up-regulated in all brain regions, alpha 6 beta 2* nAChRs were down-regulated in the nucleus accumbens (NAc) and caudate-putamen, and alpha 7 nAChRs were up-regulated in the caudal cerebral cortex (CCx); the up-regulation of alpha 4 beta 2 alpha 5 nAChRs in the CCx was also suggested. In the SA group, alpha 4 beta 2 up-regulation was lower and limited to the CCx and NAc; there were no detectable changes in alpha 6 beta 2* or alpha 7 nACRs. In the CCx of the MP rats, there was a close correlation between the increase in alpha 4 beta 2 binding and alpha 4 and beta 2 subunit levels measured by means of Western blotting, demonstrating that the up-regulation was due to an increase in alpha 4 beta 2 proteins. Western blotting also showed that the increase in the alpha 2 subunit exceeded that of the alpha 4 subunit, suggesting that a change in alpha 4 beta 2 stoichiometry may occur in vivo as has been shown in vitro. These results show that nicotine has an area-specific effect on receptor subtypes, regardless of its administration route, but the effect is quantitatively greater in the case of MP administration
A comparative study of the effects of the intravenous self-administration or subcutaneous minipump infusion of nicotine on the expression of brain neuronal nicotinic receptor subtypes.
Clementi F;Gotti C
2010
Abstract
Long-term nicotine exposure changes neuronal acetylcholine nicotinic receptor (nAChR) subtype expression in the brains of smokers and experimental animals. The aim of this study was to investigate nicotine-induced changes in nAChR expression in two models commonly used to describe the effects of nicotine in animals: operant (two-lever presses) intravenous self-administration (SA) and passive subcutaneous nicotine administration via an osmotic minipump (MP). In the MP group, alpha 4 beta 2 nAChRs were up-regulated in all brain regions, alpha 6 beta 2* nAChRs were down-regulated in the nucleus accumbens (NAc) and caudate-putamen, and alpha 7 nAChRs were up-regulated in the caudal cerebral cortex (CCx); the up-regulation of alpha 4 beta 2 alpha 5 nAChRs in the CCx was also suggested. In the SA group, alpha 4 beta 2 up-regulation was lower and limited to the CCx and NAc; there were no detectable changes in alpha 6 beta 2* or alpha 7 nACRs. In the CCx of the MP rats, there was a close correlation between the increase in alpha 4 beta 2 binding and alpha 4 and beta 2 subunit levels measured by means of Western blotting, demonstrating that the up-regulation was due to an increase in alpha 4 beta 2 proteins. Western blotting also showed that the increase in the alpha 2 subunit exceeded that of the alpha 4 subunit, suggesting that a change in alpha 4 beta 2 stoichiometry may occur in vivo as has been shown in vitro. These results show that nicotine has an area-specific effect on receptor subtypes, regardless of its administration route, but the effect is quantitatively greater in the case of MP administrationI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.